Physician

Nicholas Thomson, M.D.

According to 2025 Medicare claims, Nicholas Thomson, M.D. (NPI: 1891106936) practices hematology/oncology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84003-9998. Thomson is affiliated with the Main Street Rural Health Cedar ACO LLC (ACO ID: A5502) and Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under both the MSSP and REACH models.

Thomson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 284 traditional Medicare patients, billed 91,132 HCPCS/CPT codes, and received $1,953,728 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,443 prescription claims across 239 beneficiaries totaling $3,752,696 in drug costs, led by Verzenio (Abemaciclib). 2023 DME data shows 19 claims. Open Payments data shows 168 records totaling $8,241. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $493,688 to $1,953,728. Similarly, Part D prescription costs have risen steadily, from $6,924 to $3,752,696. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	173	29,912	$493,688
2021	247	68,067	$1,131,547
2022	250	89,769	$1,496,731
2023	258	95,911	$1,752,534
2024	284	91,132	$1,953,728

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	140	$6,924
2016	22	200	$16,586
2017	21	149	$11,305
2018	17	55	$4,531
2019	N/R	N/R	N/R
2020	40	170	$232,649
2021	153	851	$578,233
2022	172	1,041	$982,086
2023	200	1,370	$2,434,981
2024	239	1,443	$3,752,696

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	11	$1,265
2022	N/R	22	$11,767
2023	N/R	19	$11,499
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	112	225	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	94	178	$12
80053	Blood test, comprehensive group of blood chemicals	96	321	$10
36415	Insertion of needle into vein for collection of blood sample	116	316	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	122	471	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	44	1,232	$682,568
Revlimid	Lenalidomide	40	1,085	$682,057
Brukinsa	Zanubrutinib	39	1,200	$464,102
Cabometyx	Cabozantinib S-Malate	11	330	$282,848
Lenalidomide	Lenalidomide	23	644	$276,260

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	168	$8,241	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nicholas Thomson, M.D.?

Tedicare shows public-source Medicare data for Nicholas Thomson, M.D. (NPI 1891106936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas Thomson, M.D. have ACO affiliation data?

Nicholas Thomson, M.D. is shown with ACO affiliation data for Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502) and Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Nicholas Thomson, M.D.?

Nicholas Thomson, M.D. is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Nicholas Thomson, M.D. have Open Payments data?

Nicholas Thomson, M.D. has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.